Use of the endoglycosidase endos for treating immunoglobulin g mediated diseases
AssigneeHansa Medical AB
InventorsLars Bjorck, Mattias Collin, Arne Olsen, Rikard Holmdahl, Kutty Selva Nandakumar, Oonagh Shannon
Life of this patent
Estimating the term…
Abstract
The invention provides use of an EndoS polypeptide, or a polynucleotide encoding an EndoS polypeptide, in the manufacture of a medicament for the treatment or prevention of a disease or condition mediated by IgG antibodies.
Claims14
1-12. (canceled)
A method of treating or preventing a disease or condition mediated by IgG antibodies in a subject in need thereof, the method comprising administering to the subject a therapeutically effective amount of an EndoS polypeptide, or a polynucleotide encoding an EndoS polypeptide.
A method of treating, ex vivo, blood taken from a patient suffering from a disease or condition mediated by IgG antibodies, comprising contacting the blood with an EndoS polypeptide.
Dependencies are inferred from the claim text.